Arthritis Animation Rheumatology

Rheumatoid Arthritis Severity Reduced By Alcohol
Drinking alcohol may reduce the severity of rheumatoid arthritis according to new research justg published. It is the first time that this effect has been shown in humans. The study also finds that alcohol consumption reduces the risk of developing the disease, confirming the results of previous studies...

Adherence To Recommended Exercise Improves Physical Function, Reduces Pain For OA Patients
Patients with osteoarthritis (OA) of the knee or hip who adhere to the recommended home physical therapy exercises and physically active lifestyle experience more improvement in pain, physical function, and self-perceived effect according to a study from researchers in The Netherlands...

Horizon Pharma, Inc. Announces Results Of Phase 3 Study Of LODOTRA® Demonstrate 12-Month Sustained Efficacy And Safety In Rheumatoid Arthritis
Horizon Pharma, Inc...

Unigene Reports Continuation Of Phase III Study Of Oral Calcitonin In Osteoarthritis Patients
Unigene Laboratories, Inc. (OTCBB: UGNE) announced that Novartis and its license partner Nordic Bioscience [the "Sponsor"] have decided to continue the companies' two-year, Phase III Study 2302 assessing safety and efficacy of oral calcitonin in patients with osteoarthritis of the knee. Novartis has a worldwide license to produce recombinant calcitonin under Unigene's patented SecraPep® E...

Diagnostic "Guidelines" A Barrier To Prompt Relief For Some Back Pain
Slavishly following long-held guidelines for diagnosing the cause of arthritis-related back pain is resulting in excessive tests, delays in pain relief and wasteful spending of as much as $10,000 per patient, new Johns Hopkins-led research suggests...

Winston Laboratories, Inc. Receives Notice Of Compliance In Canada For CIVANEX™ (Civamide Cream) For Treatment Of Osteoarthritis
Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc...

PsoriasisDX Genetic Test For Psoriatic Arthritis Now Available In Europe As A CE Marked In Vitro Diagnostic Medical Device
Molecular dermatology research and development innovator DermaGenoma, Inc. today announced that the PsoriasisDX Genetic Test for Psoriatic Arthritis (PsA) is now available as a CE Marked product under the European In Vitro Diagnostic Directive. CE Marking is required for certain product groups to indicate conformity with the essential requirements set out in European Directives...

Need For Protection Against Ticks That Carry Lyme Disease
Research on the population of black-legged ticks, which can transmit Lyme disease from host animals to humans, reinforces that it is important to take preventative measures when spending time outdoors...

Protecting Knees Now Might Prevent Pain Later
Taking a few small steps toward protecting your knees when you are younger might help you avoid debilitating problems when you get older. Studies have shown that nearly half of adults will get knee arthritis in at least one knee by age 85. For obese people, the risk is even greater. "Every time you take a step you apply three times your body weight to the knee," said Dr. William J...

Shoulder Arthritis? What Patients Need To Know Before Treatment
The American Academy of Orthopaedic Surgeons (AAOS) has approved and released an evidence-based clinical practice guideline on "The Treatment of Glenohumeral Joint Osteoarthritis." This major joint in the shoulder - the ball and socket joint - is sometimes affected by osteoarthritis, causing pain, loss of function, and reduced quality of life...

First Complete Surgical System Specifically Designed To Treat Progressive Osteoarthritis Of The Knee Is Launched In Europe
DePuy Orthopaedics EMEA announces the introduction of Sigma® High Performance Partial Knee, the only partial knee replacement system designed to provide the complete solution to progressive osteoarthritis in active patients...

New Multi-Disciplinary Approach To Osteoarthritis Research Announced In UK
A new multi-disciplinary approach to osteoarthritis research in the UK was announced earlier this month with a 1.8 million pound programme comprising three clinical trials involving 300 people with osteoarthritis of the knee and a research team of radiologists, engineers, biomechanics, rheumatologists and physiotherapists...

Addex Drug Candidate Effective In Osteoarthritis Pain Model
Allosteric modulation company Addex Pharmaceuticals Ltd. (SWISS: ADXN) announced that its preclinical drug candidate ADX71943 was effective in a model of osteoarthritis pain. ADX71943 is a potent and selective positive allosteric modulator of gamma-aminobutyric acid subtype B (GABA-B) receptors...

Pioneering Trial To Treat Knee Arthritis With Stem Cells To Begin In UK
A pioneering trial to treat knee arthritis by using patients' own stem cells to regrow worn out cartilage is to start in the UK later this year; if successful the new technique offers hope to millions of people who suffer with the pain and stiffness of osteoarthritis, although the researchers warn that the treatment is unlikely to remove the need for joint replacement surgery...

Winston Laboratories, Inc. Submits NDA For CIVANEX(R) (Civamide Cream) For Treatment Of Osteoarthritis
Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc. ("Winston") (OTC PINK: WPHM), a pharmaceutical company focused on developing and commercializing novel pain management therapies, announced that it has submitted a new drug application (NDA) with the U.S. Food and Drug Administration (FDA) for approval to market its civamide (zucapsaicin) 0...